sulfinpyrazone has been researched along with Endocarditis in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Endocarditis: Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, CE | 1 |
| Dewar, HA | 1 |
| Barnett, HJ | 1 |
1 review available for sulfinpyrazone and Endocarditis
| Article | Year |
|---|---|
The pathophysiology of transient cerebral ischemic attacks.
Topics: Arteriosclerosis; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Embolism; Endoc | 1979 |
1 other study available for sulfinpyrazone and Endocarditis
| Article | Year |
|---|---|
Effect of sulphinpyrazone on the development of experimental endocardial vegetations.
Topics: Animals; Blood Platelets; Endocarditis; Endocardium; Fibrinolysis; Microscopy, Electron; Platelet Ad | 1982 |